Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers

Citations Over TimeTop 10% of 2012 papers

Abstract

The present findings, in combination with previously identified modifiers of risk, will ultimately lead to more accurate risk prediction and an improved understanding of the disease etiology in BRCA1 and BRCA2 mutation carriers.

Related Papers

• → ASO Author Reflections: Investigating the Relationship Between Patient Primary Language and Surgical Oncology Outcomes(2022)1 cited
• → Abstracts exchange: European Journal of Surgical Oncology(1996)
• → ASO Visual Abstract: Application and Match Rates in the Complex General Surgical Oncology Match(2022)
• → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)
• → ASO Author Reflections: Telemedicine in Surgical Oncology—Patterns and Implications for Integration(2025)